Comparative evaluation of early vs. deferred vitrectomy in Eales' disease

Area of Science:

• Ophthalmology
• Surgical Intervention
• Retinal Diseases

Background:

• Eales' disease frequently causes vitreous hemorrhage, potentially leading to vision loss.
• Vitrectomy is a surgical option for managing vitreous hemorrhage.
• The timing of vitrectomy may influence visual outcomes in Eales' disease.

Purpose of the Study:

• To compare the visual outcomes of early versus deferred vitrectomy in patients with vitreous hemorrhage secondary to Eales' disease.
• To evaluate the impact of hemorrhage duration on the success of vitrectomy.

Main Methods:

• A comparative study involving 40 patients with vitreous hemorrhage due to Eales' disease undergoing vitrectomy.
• Patients were divided into two groups: early vitrectomy (3-6 months duration) and deferred vitrectomy (>6 months duration).
• Follow-up was conducted for at least 3 months post-surgery.

Main Results:

• The early vitrectomy group achieved significantly better final visual acuity (6/9 or better in 65% of eyes) compared to the deferred group (20% of eyes) (p<0.01).
• Preoperative ultrasonic findings like posterior vitreous detachment and less mobile hemorrhage correlated with better outcomes in the early group.
• Poor outcomes in the deferred group were associated with cystoid macular edema, macular scarring, pucker, and degeneration.

Conclusions:

• Early vitrectomy for Eales' disease-related vitreous hemorrhage leads to improved visual outcomes.
• Prompt surgical intervention likely minimizes macular damage from toxic blood products and reduces tractional complications.
• Deferred vitrectomy is associated with a higher incidence of macular pathology and poorer visual results.